US equities
|
NVDA
$243.23
▲+1.81%
SPCX
$173.67
▲+1.51%
MU
$1,071.21
▲+0.68%
META
$744.29
▲+0.32%
AMD
$648.56
▲+2.66%
AMZN
$252.00
▲+0.24%
SNDK
$1,715.30
▲+0.65%
INTC
$117.78
▲+1.37%
NVDA
$243.23
▲+1.81%
SPCX
$173.67
▲+1.51%
MU
$1,071.21
▲+0.68%
META
$744.29
▲+0.32%
AMD
$648.56
▲+2.66%
AMZN
$252.00
▲+0.24%
SNDK
$1,715.30
▲+0.65%
INTC
$117.78
▲+1.37%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tarsus Pharmaceuticals, Inc. - Common Stock
(NQ:
TARS
)
74.48
+0.02 (+0.03%)
Delayed Quote
Updated: 9:30 AM EDT, Oct 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tarsus Pharmaceuticals, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Mid-Afternoon Market Update: Dow Jumps Over 500 Points; Lydall Shares Spike Higher
↗
June 21, 2021
Toward the end of trading Monday, the Dow traded up 1.71% to 33,857.87 while the NASDAQ rose 0.63% to 14,119.16. The S&P also rose, gaining 1.28% to 4,219.92. The U.S. has the...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
↗
June 21, 2021
Gainers Anavex Life Sciences (NASDAQ:AVXL) shares moved upwards by 17.07% to $25.92 during Monday's regular session. Anavex Life Sciences's stock is trading at a...
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises 1.5%; Tarsus Pharmaceuticals Shares Slide
↗
June 21, 2021
Midway through trading Monday, the Dow traded up 1.48% to 33,782.47 while the NASDAQ rose 0.74% to 14,134.01. The S&P also rose, gaining 1.17% to 4,215.39. The U.S. has the...
Via
Benzinga
Topics
Stocks
31 Stocks Moving In Monday's Mid-Day Session
↗
June 21, 2021
Gainers Lydall, Inc. (NYSE: LDL) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share. Raven Industries, Inc. (NASDAQ: RAVN)...
Via
Benzinga
Tarsus Pharmaceuticals' TP-03 Hits Primary, Secondary Endpoints In Demodex Blepharitis Study
↗
June 21, 2021
Tarsus Pharmaceuticals Inc (NASDAQ: TARS) has reported topline data from Phase 2b/3 Saturn-1 trial evaluating TP-03 (lotilaner ophthalmic solution, 0.25%) in...
Via
Benzinga
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues
↗
May 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
Next >
